These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35605658)

  • 1. Identifying chronic alcoholism drug disulfiram as a potent DJ-1 inhibitor for cancer therapeutics.
    Wu Q; Zhang M; Wen Y; He P; He Q; Yang B; Jiang L; Yuan M; Cao J
    Eur J Pharmacol; 2022 Jul; 926():175035. PubMed ID: 35605658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bis-isatin derivatives: design, synthesis, and biological activity evaluation as potent dimeric DJ-1 inhibitors.
    Chen XB; Zhu HY; Bao K; Jiang L; Zhu H; Ying MD; He QJ; Yang B; Sheng R; Cao J
    Acta Pharmacol Sin; 2021 Jul; 42(7):1160-1170. PubMed ID: 33495517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction of disulfiram and H
    Read E; Milford J; Zhu J; Wu L; Bilodeau M; Yang G
    Toxicol Appl Pharmacol; 2021 Sep; 426():115642. PubMed ID: 34242567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-hepatocellular carcinoma properties of the anti-alcoholism drug disulfiram discovered to enzymatically inhibit the AMPK-related kinase SNARK in vitro.
    Goto K; Kato N; Chung RT
    Oncotarget; 2016 Nov; 7(46):74987-74999. PubMed ID: 27602492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput chemical screens identify disulfiram as an inhibitor of human glioblastoma stem cells.
    Hothi P; Martins TJ; Chen L; Deleyrolle L; Yoon JG; Reynolds B; Foltz G
    Oncotarget; 2012 Oct; 3(10):1124-36. PubMed ID: 23165409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4.
    Skrott Z; Mistrik M; Andersen KK; Friis S; Majera D; Gursky J; Ozdian T; Bartkova J; Turi Z; Moudry P; Kraus M; Michalova M; Vaclavkova J; Dzubak P; Vrobel I; Pouckova P; Sedlacek J; Miklovicova A; Kutt A; Li J; Mattova J; Driessen C; Dou QP; Olsen J; Hajduch M; Cvek B; Deshaies RJ; Bartek J
    Nature; 2017 Dec; 552(7684):194-199. PubMed ID: 29211715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutathione-responsive copper-disulfiram nanoparticles for enhanced tumor chemotherapy.
    Chen M; Huang Z; Xia M; Ding Y; Shan T; Guan Z; Dai X; Xu X; Huang Y; Huang M; Zhao C
    J Control Release; 2022 Jan; 341():351-363. PubMed ID: 34856225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disulfiram/copper shows potent cytotoxic effects on myelodysplastic syndromes via inducing Bip-mediated apoptosis and suppressing autophagy.
    Zha J; Bi S; Deng M; Chen K; Shi P; Feng L; He J; Pu X; Guo C; Zhao H; Li Z; Jiang Y; Song H; Xu B
    Eur J Pharmacol; 2021 Jul; 902():174107. PubMed ID: 33865831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of proteasome inhibition in cancer. Can the old drug, disulfiram, have a bright new future as a novel proteasome inhibitor?
    Cvek B; Dvorak Z
    Drug Discov Today; 2008 Aug; 13(15-16):716-22. PubMed ID: 18579431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combination of disulfiram and copper for cancer treatment.
    Li H; Wang J; Wu C; Wang L; Chen ZS; Cui W
    Drug Discov Today; 2020 Jun; 25(6):1099-1108. PubMed ID: 32320854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacology of disulfiram - an update].
    Mutschler J; Diehl A; Kiefer F
    Fortschr Neurol Psychiatr; 2008 Apr; 76(4):225-31. PubMed ID: 18415930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disulfiram/copper markedly induced myeloma cell apoptosis through activation of JNK and intrinsic and extrinsic apoptosis pathways.
    Xu Y; Zhou Q; Feng X; Dai Y; Jiang Y; Jiang W; Liu X; Xing X; Wang Y; Ni Y; Zheng C
    Biomed Pharmacother; 2020 Jun; 126():110048. PubMed ID: 32145587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The disulfiram/copper complex induces apoptosis and inhibits tumour growth in human osteosarcoma by activating the ROS/JNK signalling pathway.
    Guo W; Zhang X; Lin L; Wang H; He E; Wang G; Zhao Q
    J Biochem; 2021 Oct; 170(2):275-287. PubMed ID: 33792698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disulfiram Synergizes with SRC Inhibitors to Suppress the Growth of Pancreatic Ductal Adenocarcinoma Cells in Vitro and in Vivo.
    Li Z; Xie X; Tan G; Xie F; Liu N; Li W; Sun X
    Biol Pharm Bull; 2021; 44(9):1323-1331. PubMed ID: 34471060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two clinical drugs deubiquitinase inhibitor auranofin and aldehyde dehydrogenase inhibitor disulfiram trigger synergistic anti-tumor effects in vitro and in vivo.
    Huang H; Liao Y; Liu N; Hua X; Cai J; Yang C; Long H; Zhao C; Chen X; Lan X; Zang D; Wu J; Li X; Shi X; Wang X; Liu J
    Oncotarget; 2016 Jan; 7(3):2796-808. PubMed ID: 26625200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancer.
    Allensworth JL; Evans MK; Bertucci F; Aldrich AJ; Festa RA; Finetti P; Ueno NT; Safi R; McDonnell DP; Thiele DJ; Van Laere S; Devi GR
    Mol Oncol; 2015 Jun; 9(6):1155-68. PubMed ID: 25769405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressing autophagy enhances disulfiram/copper-induced apoptosis in non-small cell lung cancer.
    Wu X; Xue X; Wang L; Wang W; Han J; Sun X; Zhang H; Liu Y; Che X; Yang J; Wu C
    Eur J Pharmacol; 2018 May; 827():1-12. PubMed ID: 29547841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disulfiram, a drug widely used to control alcoholism, suppresses the self-renewal of glioblastoma and over-rides resistance to temozolomide.
    Triscott J; Lee C; Hu K; Fotovati A; Berns R; Pambid M; Luk M; Kast RE; Kong E; Toyota E; Yip S; Toyota B; Dunn SE
    Oncotarget; 2012 Oct; 3(10):1112-23. PubMed ID: 23047041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing Disulfiram as a Chemo-Therapeutic Sensitizer: Molecular Targets and Mechanisms.
    Sun F; Wang H; Nie J; Hong B
    Anticancer Agents Med Chem; 2022; 22(17):2920-2926. PubMed ID: 35430981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disulfiram, an old drug with new potential therapeutic uses for human hematological malignancies.
    Conticello C; Martinetti D; Adamo L; Buccheri S; Giuffrida R; Parrinello N; Lombardo L; Anastasi G; Amato G; Cavalli M; Chiarenza A; De Maria R; Giustolisi R; Gulisano M; Di Raimondo F
    Int J Cancer; 2012 Nov; 131(9):2197-203. PubMed ID: 22322883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.